Which is more profitable, Merck & or Moderna?

Merck & keeps more of every sale as profit.

Which grows faster, Merck & or Moderna?

Moderna grew its sales faster in recent years.

Which is cheaper, Merck & or Moderna?

Merck & costs less for each unit of yearly profit (lower P/E).

Which has less debt, Merck & or Moderna?

Moderna would need fewer years of earnings to pay off its debt.

Merck &MRKvs

ModernaMRNA

Merck & vs Moderna stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Merck & is more profitable and is cheaper for its profits. Moderna grows faster and has less debt.

Side by side

	Merck &	Moderna
	$364 billion	$90.4 billion
	28.1%	-146.8%
	+9.4%	+19.1%
	20.0×	No profit yet
	1.2 years	Net cash
	17.8%	-22.4%
	2.8%	–

Open Merck &Open Moderna

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Merck & vs Pfizer · Merck & vs Regeneron Pharmaceuticals · Merck & vs Roche · Merck & vs Sanofi · Moderna vs Roche · Moderna vs UnitedHealth · Moderna vs AbbVie · Moderna vs Johnson & Johnson